| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals, Inc. (EGRX) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. EGRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2016 | Tarriff Scott | President And CEO | Sell | 18,360 | $68.08 | $1,249,974.34 | -0.3% | |
| Jan 4, 2016 | Tarriff Scott | President And CEO | Sell | 14,549 | $85.91 | $1,249,920.86 | -0.5% | |
| Dec 22, 2015 | Flaum Sander A | Director | Sell | 13,025 | $54.81 | $713,959.88 | -26.6% | |
| Dec 1, 2015 | Tarriff Scott | President And CEO | Sell | 14,050 | $88.93 | $1,249,418.92 | -0.2% | |
| Nov 2, 2015 | Tarriff Scott | President And CEO | Sell | 19,339 | $64.63 | $1,249,954.91 | -0.7% | |
| Oct 1, 2015 | Tarriff Scott | President And CEO | Sell | 17,878 | $69.92 | $1,249,964.73 | -0.2% | |
| Sep 1, 2015 | Tarriff Scott | President And CEO | Sell | 16,245 | $76.95 | $1,249,998.04 | -0.3% | |
| Aug 3, 2015 | Tarriff Scott | President And CEO | Sell | 13,000 | $96.19 | $1,250,408.26 | -0.4% | |
| Jul 1, 2015 | Tarriff Scott | President And CEO | Sell | 135,710 | $46.34 | $6,288,854.74 | -1.7% | |
| Jun 16, 2015 | Krill Steven L. | Chief Scientific Officer | Sale+OE | 9,980 | $81.60 | $814,368.00 | -100% |